-
Cancer Did Not Cancel Our Plans
After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.
by Miriam Díaz-Gilbert
-
A Drive for Diversity
African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
Survival Statistics 101
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
-
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Living Beyond a Diagnosis
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
-
On Being Asked Not to Tell: Hiding Illness From Loved Ones
Keeping her grandfather's cancer a secret from him felt counterintuitive to Tina Chai as a teen, but conversations with other Chinese Americans helped her understand the reasons Chinese physicians and families may practice cancer nondisclosure.
by Tina Chai
-
Cancer and COVID-19 Vaccination
Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
-
Colorectal Cancer Screenings at Home
Stool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore